Intrexon Corp. Company Profile (NYSE:XON)

About Intrexon Corp.

Intrexon Corp. logoIntrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. Its technologies combine the principles of precision engineering, statistical modeling, automation and production at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing, or LEAP, and ActoBiotics platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: XON
  • CUSIP:
Key Metrics:
  • Previous Close: $26.12
  • 50 Day Moving Average: $26.63
  • 200 Day Moving Average: $29.53
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -39.58
  • P/E Growth: 0.45
  • Market Cap: $3.09B
  • Outstanding Shares: 118,325,000
  • Beta: 1.54
Additional Links:
Companies Related to Intrexon Corp.:

Analyst Ratings

Consensus Ratings for Intrexon Corp. (NYSE:XON) (?)
Ratings Breakdown: 2 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $45.17 (72.92% upside)

Analysts' Ratings History for Intrexon Corp. (NYSE:XON)
Show:
DateFirmActionRatingPrice TargetDetails
8/16/2016Griffin SecuritiesReiterated RatingBuy$55.00View Rating Details
7/17/2016JMP SecuritiesReiterated RatingBuyView Rating Details
7/7/2016WunderlichReiterated RatingBuy$50.00View Rating Details
6/29/2016Stifel NicolausReiterated RatingBuy$57.00View Rating Details
3/3/2016Bank of America Corp.Reiterated RatingNeutral$41.00 -> $38.00View Rating Details
3/1/2016MizuhoReiterated RatingNeutral$28.00 -> $29.00View Rating Details
8/11/2015Merriman CapitalUpgradeNeutral -> Buy$85.00View Rating Details
8/11/2015JPMorgan Chase & Co.DowngradeOverweight -> Neutral$45.00 -> $55.00View Rating Details
(Data available from 8/29/2014 forward)

Earnings

Earnings History for Intrexon Corp. (NYSE:XON)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q216($0.26)($0.42)$53.78 million$52.50 millionViewN/AView Earnings Details
5/10/2016Q1($0.20)($0.55)$46.26 million$43.40 millionViewListenView Earnings Details
2/29/2016Q415($0.18)($0.28)$41.82 million$41.50 millionViewListenView Earnings Details
11/9/2015Q3($0.21)($0.34)$40.84 million$53.40 millionViewN/AView Earnings Details
8/10/2015Q215($0.04)$0.01$55.93 million$44.90 millionViewListenView Earnings Details
5/11/2015Q115($0.12)$0.25$32.90 million$33.80 millionViewListenView Earnings Details
3/2/2015Q414($0.16)$0.18$26.11 million$31.10 millionViewN/AView Earnings Details
11/13/2014Q314($0.16)($0.53)$19.40 million$21.20 millionViewN/AView Earnings Details
8/14/2014Q214($0.13)($0.11)$9.39 million$11.80 millionViewN/AView Earnings Details
5/7/2014Q1$0.06$0.04$11.25 million$7.90 millionViewN/AView Earnings Details
3/31/2014Q413($0.14)($0.13)$8.38 million$7.10 millionViewN/AView Earnings Details
11/7/2013($0.03)$0.15$9.79 million$6.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intrexon Corp. (NYSE:XON)
Current Year EPS Consensus Estimate: $-1.36 EPS
Next Year EPS Consensus Estimate: $-0.66 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.22)($0.21)($0.22)
Q2 20162($0.22)($0.21)($0.22)
Q3 20162($0.26)($0.22)($0.24)
Q4 20162($0.27)($0.18)($0.23)
Q1 20171($0.26)($0.26)($0.26)
Q2 20171($0.24)($0.24)($0.24)
Q3 20171($0.26)($0.26)($0.26)
Q4 20171($0.24)($0.24)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intrexon Corp. (NYSE:XON)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intrexon Corp. (NYSE:XON)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/13/2016Randal J KirkCEOBuy41,830$23.92$1,000,573.60View SEC Filing  
12/11/2015Randal J KirkCEOBuy124,475$29.85$3,715,578.75View SEC Filing  
12/7/2015Randal J KirkCEOBuy237,525$30.69$7,289,642.25View SEC Filing  
12/4/2015Suma KrishnanSVPSell20,900$35.66$745,294.00View SEC Filing  
1/27/2015Randal J KirkCEOBuy555,556$27.00$15,000,012.00View SEC Filing  
5/13/2014Donald LehrInsiderBuy1,850$15.99$29,581.50View SEC Filing  
5/13/2014Randal KirkCEOBuy65,173$15.19$989,977.87View SEC Filing  
5/9/2014Kelly HuangSVPBuy3,200$15.78$50,496.00View SEC Filing  
5/9/2014Krish KrishnanCOOBuy20,900$14.21$296,989.00View SEC Filing  
3/27/2014Randal KirkCEOBuy243,001$25.72$6,249,985.72View SEC Filing  
3/4/2014Gregory Ian FrostSVPBuy100,000$25.95$2,595,000.00View SEC Filing  
8/13/2013Jeffrey B KindlerDirectorBuy33,000$16.00$528,000.00View SEC Filing  
8/13/2013Randal J KirkCEOBuy1,887,500$16.00$30,200,000.00View SEC Filing  
8/13/2013Thomas D ReedInsiderBuy1,800$16.00$28,800.00View SEC Filing  
8/13/2013Thomas R KasserSVPBuy5,000$16.00$80,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Intrexon Corp. (NYSE:XON)
DateHeadline
News IconPublic comments so far show support for 3rd GMO apple (NYSE:XON)
www.foodsafetynews.com - August 26 at 11:14 AM
capitalcube.com logoIntrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : August 26, 2016 (NYSE:XON)
www.capitalcube.com - August 26 at 11:14 AM
capitalcube.com logoETF’s with exposure to Intrexon Corp. : August 26, 2016 (NYSE:XON)
www.capitalcube.com - August 26 at 11:14 AM
News IconMatthew Crisp – President and CEO of Benson Hill Biosystems (NYSE:XON)
ideamensch.com - August 25 at 5:43 AM
publicnow.com logoOragenics Selects New Lantibiotic for Further Development in Clostridium difficile Infections (NYSE:XON)
www.publicnow.com - August 23 at 10:47 AM
bizjournals.com logoFlorida controversy stops genetically modified mosquitoes from fighting Zika in the U.S. (NYSE:XON)
www.bizjournals.com - August 20 at 7:51 PM
bizjournals.com logoThe controversy that’s stopping genetically modified mosquitoes from fighting Zika in the U.S. (NYSE:XON)
www.bizjournals.com - August 19 at 11:21 AM
fool.com logoWhat Zika Virus in Florida Means (and Doesn't Mean) for Intrexon (NYSE:XON)
www.fool.com - August 19 at 11:21 AM
bizjournals.com logoThe controversy that's stopping genetically modified mosquitoes from fighting Zika in the U.S. - Washington Business Journal (NYSE:XON)
www.bizjournals.com - August 18 at 8:34 PM
finance.yahoo.com logoINTREXON CORP Financials (NYSE:XON)
finance.yahoo.com - August 18 at 8:34 PM
finance.yahoo.com logoHow calls are playing for rally in Intrexon (NYSE:XON)
finance.yahoo.com - August 17 at 8:41 PM
finance.yahoo.com logoBullish bets on Intrexon, gold (NYSE:XON)
finance.yahoo.com - August 17 at 8:41 PM
capitalcube.com logoETF’s with exposure to Intrexon Corp. : August 15, 2016 (NYSE:XON)
www.capitalcube.com - August 15 at 8:42 PM
News IconStocks on Trader's Radar: Intrexon Corp (NYSE:XON), Brocade Communications Systems, Inc.(NASDAQ:BRCD) - NYSE Journal (press release) (NYSE:XON)
stockznews.com - August 15 at 10:24 AM
seekingalpha.com logoIntrexon EPS of -$0.42 - Seeking Alpha (NYSE:XON)
seekingalpha.com - August 11 at 9:01 PM
seekingalpha.com logoIntrexon's (XON) CEO Randal Kirk on Q2 2016 Results - Earnings ... - Seeking Alpha (NYSE:XON)
seekingalpha.com - August 11 at 9:01 PM
News IconTechnical Evaluation For Intrexon Corp (NYSE:XON) - The Voice Registrar (NYSE:XON)
voiceregistrar.com - August 11 at 9:01 PM
finance.yahoo.com logoArctic® Fuji apple one step closer to U.S. regulatory approval (NYSE:XON)
finance.yahoo.com - August 11 at 11:51 AM
fool.com logoWhy ZIOPHARM Oncology's Stock Broke Down in July (NYSE:XON)
www.fool.com - August 11 at 11:51 AM
capitalcube.com logoIntrexon Corp. :XON-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 (NYSE:XON)
www.capitalcube.com - August 11 at 11:51 AM
finance.yahoo.com logoIntrexon CEO on Zika: We're working closely with FDA (NYSE:XON)
finance.yahoo.com - August 10 at 9:07 PM
finance.yahoo.com logoIntrexon (XON) Reports Wider Loss in Q2, Revenues Increase (NYSE:XON)
finance.yahoo.com - August 10 at 9:07 PM
fool.com logoIntrexon's Revenue Grows 17%. Here's Why Investors Should Be Worried. (NYSE:XON)
www.fool.com - August 10 at 9:07 PM
finance.yahoo.com logoEdited Transcript of XON earnings conference call or presentation 9-Aug-16 9:30pm GMT (NYSE:XON)
finance.yahoo.com - August 10 at 11:40 AM
4-traders.com logoIntrexon : Announces Second Quarter and First Half 2016 Financial Results (NYSE:XON)
www.4-traders.com - August 9 at 8:43 PM
equities.com logoIntrexon Corporation (XON) Drops 5.78% on August 08 (NYSE:XON)
www.equities.com - August 9 at 8:43 PM
marketwatch.com logo10-Q: INTREXON CORP (NYSE:XON)
www.marketwatch.com - August 9 at 8:43 PM
sg.finance.yahoo.com logoIntrexon reports 2Q loss (NYSE:XON)
sg.finance.yahoo.com - August 9 at 8:43 PM
prnewswire.com logoIntrexon Appoints Dr. Andrew J. Last as Chief Operating Officer (NYSE:XON)
www.prnewswire.com - August 9 at 11:53 AM
twst.com logoIntrexon Corporation: Intrexon Appoints Dr. Andrew J. Last as Chief Operating Officer (NYSE:XON)
www.twst.com - August 9 at 11:53 AM
schaeffersresearch.com logoIntrexon Corp (XON) Appoints New COO Ahead of Earnings (NYSE:XON)
www.schaeffersresearch.com - August 9 at 11:53 AM
bizjournals.com logoIntrexon subsidiary gets OK to test genetically engineered mosquitoes in U.S. (NYSE:XON)
www.bizjournals.com - August 9 at 11:53 AM
News IconHC Stocks News Ring: Agenus Inc (NASDAQ:AGEN), Intrexon Corp ... - share market updates (press release) (NYSE:XON)
sharemarketupdates.com - August 8 at 8:36 PM
finance.yahoo.com logoWhat's in Store for Intrexon (XON) This Earnings Season? (NYSE:XON)
finance.yahoo.com - August 8 at 5:31 AM
huffingtonpost.com logoGenetically Modified Mosquitoes Approved By FDA To Fight Zika In Florida (NYSE:XON)
www.huffingtonpost.com - August 7 at 7:55 PM
News IconGenetically Modified Mosquitoes Could Fight Zika (NYSE:XON)
www.newsweek.com - August 7 at 7:55 PM
News IconFDA Approves Release of GMO Mosquitoes To Help Fight Zika (NYSE:XON)
thesource.com - August 7 at 7:55 PM
News IconUS closer to using genetically modified mosquitoes that could fight Zika (NYSE:XON)
www.timesofmalta.com - August 6 at 10:55 AM
News IconUS closer to testing engineered mosquitoes that could fight Zika (NYSE:XON)
www.netindia123.com - August 6 at 10:55 AM
News IconGM mosquito trial will not significantly impact environment: FDA (NYSE:XON)
kfgo.com - August 6 at 10:55 AM
News IconAnalyst Research and Recommendations: Intrexon Corporation (NYSE:XON), Devon Energy Corporation (NYSE:DVN) - TWN (NYSE:XON)
thewellesleysnews.com - August 5 at 8:35 PM
finance.yahoo.com logoFDA Publishes Final Finding of No Significant Impact and Environmental Assessment on Oxitec's Self-limiting Mosquito (NYSE:XON)
finance.yahoo.com - August 5 at 11:29 AM
bloomberg.com logoGene-Engineered Mosquito Trial Cleared by FDA for Florida Start (NYSE:XON)
www.bloomberg.com - August 5 at 11:29 AM
equities.com logoIntrexon Corporation (XON) Jumps 8.23% on August 03 - Equities.com (NYSE:XON)
www.equities.com - August 4 at 8:51 PM
finance.yahoo.com logoThese Two Companies Are Working On The Zika Virus Cure (NYSE:XON)
finance.yahoo.com - August 4 at 8:51 PM
capitalcube.com logoETF’s with exposure to Intrexon Corp. : August 4, 2016 (NYSE:XON)
www.capitalcube.com - August 4 at 8:51 PM
finance.yahoo.com logoFlorida May Consider Use Of Scientifically Engineered Mosquitoes To Battle Zika (NYSE:XON)
finance.yahoo.com - August 4 at 8:51 PM
foxnews.com logoWith FDA approval, GM mosquitoes could join Florida's Zika fight (NYSE:XON)
www.foxnews.com - August 4 at 11:40 AM
publicnow.com logoFibrocell Reports Second Quarter 2016 Financial Results and Recent Operational Highlights (NYSE:XON)
www.publicnow.com - August 4 at 11:40 AM
streetinsider.com logoForm 4 INTREXON CORP For: Jul 29 Filed by: Frank Steven - StreetInsider.com (NYSE:XON)
www.streetinsider.com - August 3 at 11:43 AM

Social

Intrexon Corp. (NYSE:XON) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff